S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
MarketsFN
Home/Hedge Funds/RTW Investments/Q2 2020

RTW Investments

Period: Q2 2020 Β· Filed: 2020-08-14
View on SEC EDGAR β†—
AUM
$3.55B
Total portfolio value
Positions
77
Reported securities
Top Holding
RCKT
9.9% $351.9M
QoQ Changes
+8 / -5
new Β· exited
⚠️13F Filing Disclosure

AUM figures shown are calculated by summing the reported market value of all positions in SEC 13F-HR filings β€” not the fund's actual assets under management.

  • Excludes cash, bonds, private equity, short positions, and foreign-listed stocks not required to be reported.
  • For PUT and CALL options, the reported Value is the notional value of the underlying shares β€” not the option premium paid. This significantly overstates the actual capital at risk.
  • Actual fund AUM is typically higher and includes strategies, instruments, and positions that never appear in a 13F.
  • 13F filings cover institutional managers with β‰₯$100M in 13F securities. Positions reflect end-of-quarter holdings, disclosed up to 45 days after the period ends.

Data sourced from SEC EDGAR. This tracker is for informational purposes only and does not constitute investment advice.

Portfolio Holdings

Top 30 positions

⚠️ Performance % calculated from filing date ( 2020-08-14) shown is the underlying stock price movement β€” not the derivative's P&L.
TickerIssuerNotionalPort %@ FilingNow (EOD)Since FilingAllocation
RCKTRocket Pharmaceuticals Inc$351.9M9.90%$20.93$3.84-81.7%
9.9%
ALNYAlnylam Pharmaceuticals Inc$249.1M7.01%$148.11$312.78+111.2%
7.0%
PTCTPTC Therapeutics Inc$201.1M5.66%$50.74$83.31+64.2%
5.7%
DRNADicerna Pharmaceuticals Inc$181.7M5.11%β€”β€”
5.1%
ADVMAdverum Biotechnologies Inc$141.8M3.99%β€”β€”
4.0%
IMVTImmunovant Inc$139.2M3.92%$24.35$38.79+59.3%
3.9%
AXSMAxsome Therapeutics Inc$136.4M3.84%$82.28$244.31+196.9%
3.8%
MRTXMirati Therapeutics Inc$124.2M3.49%β€”β€”
3.5%
RNAMAvidity Biosciences Inc$103.9M2.92%β€”β€”
2.9%
MYOKMyokardia Inc$90.5M2.55%β€”β€”
2.5%
MASIMasimo Corp$88.6M2.49%$227.99β€”
2.5%
STOKStoke Therapeutics Inc$84.5M2.38%$23.83$32.70+37.2%
2.4%
BAXBaxter Intl Inc$83.5M2.35%$76.83$22.65-70.5%
2.4%
CERNCerner Corp$81.0M2.28%β€”β€”
2.3%
NTRANatera Inc$76.2M2.14%$49.86$279.32+460.2%
2.1%
TBIOTranslate Bio Inc$66.6M1.87%β€”$0.05
1.9%
RLMDRelmada Therapeutics Inc$66.3M1.86%$44.75$6.28-86.0%
1.9%
AXNXAxonics Modulation Technolog$66.1M1.86%β€”β€”
1.9%
FIXXHomology Medicines Inc$66.1M1.86%β€”β€”
1.9%
BLUBellus Health Inc New$61.5M1.73%β€”β€”
1.7%
PTGXProtagonist Therapeutics Inc$59.8M1.68%$17.66$131.62+645.3%
1.7%
TNDMTandem Diabetes Care Inc$59.2M1.67%$98.92$15.32-84.5%
1.7%
TXG10x Genomics Inc$56.8M1.60%$89.31$39.01-56.3%
1.6%
OYSTOyster Pt Pharma Inc$55.1M1.55%β€”β€”
1.6%
VCELVericel Corp$53.2M1.50%$13.82$46.98+239.9%
1.5%
AGENAgenus Inc$50.6M1.42%$77.13$3.49-95.5%
1.4%
FREQFrequency Therapeutics Inc$50.3M1.41%β€”β€”
1.4%
ESTAEstablishment Labs Hldgs Inc$43.3M1.22%$18.68$89.25+377.8%
1.2%
AVDLXXXXAvadel Pharmaceuticals plc$42.9M1.21%β€”β€”
1.2%
DMTKQDermTech Inc$37.8M1.06%β€”β€”
1.1%

Quarter-on-Quarter Activity

Q2 2020 vs. Q1 2020

New Positions (8)

TickerIssuerNotionalSince Filing
RNAMAvidity Biosciences Inc$103.9M
BAXBaxter Intl Inc$83.5M-70.5%
CERNCerner Corp$81.0M
MGNXMacroGenics Inc$34.8M
CLDXCelldex Therapeutics Inc New$33.9M
ISEEIVERIC bio Inc$33.6M
ADAPYAdaptimmune Therapeutics PLC$26.0M
OSUROraSure Technologies Inc$17.9M

Exited Positions (5)

TickerIssuerNotional
BMYBristol-Myers Squibb Co$94.0M
ZBHZimmer Biomet Holdings Inc$67.9M
SRPTSarepta Therapeutics Inc$51.8M
GBTGlobal Blood Therapeutics In$36.8M
Vivus Inc 4.5 05/01/2020$3.0M

Increased (8)

TickerIssuerNotionalShares Ξ”Since Filing
TXG10x Genomics Inc$45.0M+234.6%-56.3%
OYSTOyster Pt Pharma Inc$21.2M+96.9%
AXSMAxsome Therapeutics Inc$74.5M+57.5%+196.9%
RLMDRelmada Therapeutics Inc$32.7M+50.4%-86.0%
CTMXCytomx Therapeutics Inc$4.4M+42.0%
TNDMTandem Diabetes Care Inc$30.7M+35.0%-84.5%
ODTCOdonate Therapeutics Inc$10.3M+31.4%
IMVTImmunovant Inc$73.3M+29.2%+59.3%

Trimmed (8)

TickerIssuerNotionalShares Ξ”Since Filing
STAASTAAR Surgical Co$-2.8M-54.3%
ARVNArvinas Inc$-8.1M-49.5%
WVEWAVE Life Sciences Ltd$-6.9M-29.5%
VCELVericel Corp$12.3M-13.7%+239.9%
NSTGQNanoString Technologies Inc$2.3M-10.6%
AGENAgenus Inc$18.5M-1.8%-95.5%
FIXXHomology Medicines Inc$-2.3M-1.1%
XGNExagen Inc$-4.4M+0.0%
← Back to Hedge Funds